Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03542123
Other study ID # 700003-02
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 5, 2018
Est. completion date July 1, 2019

Study information

Verified date August 2018
Source NeuroTronik Inc.
Contact Adrian Ebner, Medical Doctor
Phone 011 595 21 202767
Email adrian_ebner@yahoo.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A single-arm study to observe NeuroTronik Cardiac Autonomic Nerve Stimulation (CANS) Therapy System hemodynamic and other physiologic effects.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date July 1, 2019
Est. primary completion date June 1, 2019
Accepts healthy volunteers No
Gender All
Age group 21 Years to 75 Years
Eligibility Inclusion Criteria:

- Normal sinus rhythm by ECG

- Men and women 21-75 years old

- Patients with stable symptomatic heart failure, New York Heart Association (NYHA) class II, III, or IV.

Exclusion Criteria:

- Systolic Blood Pressure < 90 mmHg or > 160 mmHg

- Current amiodarone therapy or any other antiarrhythmic therapy

- Coronary artery bypass graft surgery or percutaneous coronary intervention within prior 1 month

- Enzyme-positive MI within prior 1 month

- Patients who have been hospitalized for heart failure and who required the use of HF IV therapy within 30 days before enrollment (measured from release)

- History of recent severe ventricular arrhythmias

- Pre-existing carotid artery or cerebral disease

- Patients with hypertrophic obstructive cardiomyopathy or infiltrative cardiomyopathy (e.g. amyloidosis, sarcoidosis)

- Patients with prior vagalotomy

- Patients with current or prior vagal nerve stimulators

- Subjects with narrow angle glaucoma

- Renal failure - on dialysis or serum creatinine > 2.0 mg/dl

- Hepatic failure - bilirubin, SGOT, or SGPT > 4X upper limit of normal

- Patients with a life expectance < 12 months per physician judgment

- Women who are pregnant

- Allergy to fentanyl, midazolam, propofol, eggs, egg products, soybeans, or soy products

- Subjects unwilling or unable to provide consent for the protocol

Study Design


Related Conditions & MeSH terms


Intervention

Device:
NeuroTronik CANS Therapy® System
The NeuroTronik CANS Therapy® System is a percutaneous, catheter-based, bedside electrical stimulation system. The System consists of the single-use, disposable NeuroCatheter™ and NeuroCatheter™ Placement Kit, along with the reusable, bedside NeuroModulator™ Development System, and the NeuroTronik CANS Therapy™ Cable.

Locations

Country Name City State
Paraguay Sanatorio Italiano Asunción

Sponsors (1)

Lead Sponsor Collaborator
NeuroTronik Inc.

Country where clinical trial is conducted

Paraguay, 

Outcome

Type Measure Description Time frame Safety issue
Primary Left ventricular pressure and volume One hour
Secondary Heart rate One hour
See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Active, not recruiting NCT05896904 - Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction N/A
Completed NCT05077293 - Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
Recruiting NCT05631275 - The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
Enrolling by invitation NCT05564572 - Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology N/A
Enrolling by invitation NCT05009706 - Self-care in Older Frail Persons With Heart Failure Intervention N/A
Recruiting NCT04177199 - What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
Terminated NCT03615469 - Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY) N/A
Recruiting NCT06340048 - Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure Phase 1/Phase 2
Recruiting NCT05679713 - Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
Completed NCT04254328 - The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure N/A
Completed NCT03549169 - Decision Making for the Management the Symptoms in Adults of Heart Failure N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05538611 - Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
Recruiting NCT04262830 - Cancer Therapy Effects on the Heart
Completed NCT06026683 - Conduction System Stimulation to Avoid Left Ventricle Dysfunction N/A
Withdrawn NCT03091998 - Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support Phase 1
Recruiting NCT05564689 - Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy